{
    "title": "Argenx profits jump as Vyvgart sales beat forecasts",
    "modified_at": "2026-05-07 12:50:04",
    "published_at": "2026-05-07 12:50:00",
    "url": "https://www.belganewsagency.eu/argenx-profits-jump-as-vyvgart-sales-beat-forecasts",
    "short_url": "http://prez.ly/anGd",
    "culture": "en_BE",
    "language": "EN",
    "slug": "argenx-profits-jump-as-vyvgart-sales-beat-forecasts",
    "body": "<p><strong>Belgian-Dutch biotech firm Argenx nearly tripled its quarterly operating profit after strong sales of its rare disease treatment Vyvgart.</strong></p><p>Vyvgart generated 1.3 billion dollars (1.1 billion euros) in revenue during the first quarter, up 63 per cent from a year earlier. The figure was slightly above analysts&rsquo; expectations.</p><p>Operating profit rose sharply to 394 million dollars (335 million euros) from 138.9 million dollars a year ago. Net profit also increased to 366 million dollars.</p><p>Vyvgart is used to treat several rare immune-related conditions, including myasthenia gravis, CIDP and ITP. The medicine has now recorded sales growth for 17 consecutive quarters.</p><p>The results are the first under <a href=\"http://prez.ly/lk4d\" target=\"_blank\" rel=\"noreferrer noopener\">new chief executive Karen Massey</a>, who officially took over from Tim Van Hauwermeiren at the company&rsquo;s shareholder meeting on Wednesday. Van Hauwermeiren, a co-founder of the business, has become chairman after leading the company for 18 years.</p><p>Argenx is also awaiting a decision from the US Food and Drug Administration on extending approval for Vyvgart to more patients with myasthenia gravis.</p><p>&nbsp;</p><p><sup>#FlandersNewsService | EU and Belgian officials visit argenx in Zwijnaarde, February 2024 &copy; BELGA PHOTO BENOIT DOPPAGNE</sup></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>",
    "header": {
        "large": "https://cdn.uc.assets.prezly.com/ece2304f-6b8b-4df0-97c3-29f9fbf011e8/-/preview/1200x1200/-/format/auto/",
        "release": "https://cdn.uc.assets.prezly.com/ece2304f-6b8b-4df0-97c3-29f9fbf011e8/-/preview/1200x1200/-/format/auto/"
    },
    "author": {
        "first_name": "Flanders",
        "last_name": "News Service"
    },
    "format_version": 5
}